Lung cancer patients with moderate to severe depression are 2 to 3 times more likely to have inflammation levels that predict poor survival rates, a new study found.
The results may help explain why a substantial portion of lung cancer patients fail to respond to new immunotherapy and targeted treatments that have led to significantly longer survival for many people with the disease.

“These patients with high levels of depression are at much higher risk for poor outcomes,” said Barbara Andersen, one of the lead authors of the study and professor of psychology at The Ohio State University.
“Depression levels may be as important or even more important than other factors that have been associated with how people fare with lung cancer.”
Thank you for your posts, Tony! I have learned a lot of new health information from them and appreciate it very much!
–Janine Perky
LikeLike
Now, that’s a depressing thought. All the more reason to be kind and supportive of people who are not well.
LikeLiked by 2 people
Amen, Jasper.
LikeLike
Whoa! I just came back to reading blogs and this is the first one I see…very interesting. As a Stage 4 lung cancer survivor and depression sufferer, I never knew this.
LikeLiked by 2 people
I am just recovering from lung cancer surgery and am finding out that there is always more to learn about it. Good luck with yours. https://guysandgoodhealth.com/2022/12/22/what-you-can-learn-from-my-lung-cancer/
LikeLiked by 2 people